Page 33 - IACC Newsletter October November 2013 Issue 13

Basic HTML Version

Laurus was set up by Satyanarayana, former chief operating officer of Matrix Laboratories, in 2005. The Rs 800-crore
company is a leading manufacturer of active pharmaceutical ingredients (APIs) for anti-retroviral (HIV-AIDS), oncology and
nutraceuticals, and a supplier of leading generic pharmaceutical companies in India and abroad. In addition to the API
business, the company has a contract research and manufacturing business offering services to a few global
pharmaceutical companies.
Laurus has a state-of-the-art research & development and scale-up laboratory in Hyderabad and large-scale manufacturing
facilities at Visakhapatnam. These export-oriented units have been accredited by international regulatory agencies
including the US FDA, UK MHRA, Australian TGA and Korean FDA.
Advent International has exposure to the Indian health care sector through its $110-million (Rs 560 crore) investment in
the Hyderabad-based hospital chain Care Hospitals in April 2012.
The pharmaceutical industry in India is set to witness more deals in 2014 after seeing some of the largest deals in
December 2013. According to data from VCCEdge, the pharmaceutical industry has seen eight PE/ VC deals worth $387
million in 2013, against 11 deals worth $151 million in the previous year, a growth of 156 per cent.
Copyright © Business Standard Ltd. All Rights Reserved.